American Realty Capital Properties (NASDAQ:ARCP) Director Scott Bowman acquired 10,000 shares of the stock on the open market in a transaction that occurred on Wednesday, May 21st. The stock was purchased at an average cost of $12.27 per share, for a total transaction of $122,700.00. Following the completion of the purchase, the director now directly owns 2,000 shares of the company’s stock, valued at approximately $24,540. American Realty Capital Properties Inc (NASDAQ:ARCP) weekly performance is -6.11%. On last trading day company shares ended up $12.30. Analysts mean target price for the company is $16.60. American Realty Capital Properties Inc (NASDAQ:ARCP) distance from 50-day simple moving average (SMA50) is -8.00%.
You On Demand Holdings (NYSE:YOD) major shareholder Shane Mcmahon bought 24,600 shares of the company’s stock in a transaction dated Thursday, May 22nd. The shares were purchased at an average cost of $2.19 per share, for a total transaction of $53,874.00. Following the completion of the acquisition, the insider now directly owns 2,300,000 shares in the company, valued at approximately $5,037,000. You On Demand Holdings, Inc. (NASDAQ:YOD) shares advanced 49.54% in last trading session and ended the day on $3.23. YOD return on assets is -46.70%. You On Demand Holdings, Inc. (NASDAQ:YOD) quarterly performance is -43.23%.
Liquid Holdings Group (NASDAQ:LIQD) CEO Brian M. Storms bought 100,000 shares of Liquid Holdings Group stock on the open market in a transaction dated Friday, May 16th. The stock was purchased at an average cost of $1.26 per share, for a total transaction of $126,000.00. Following the acquisition, the chief executive officer now directly owns 1,621,545 shares of the company’s stock, valued at approximately $2,043,147. Liquid Holdings Group Inc (NASDAQ:LIQD) shares moved down -5.56% in last trading session and was closed at $1.70, while trading in range of $1.67 – $1.99. Liquid Holdings Group Inc (NASDAQ:LIQD) year to date (YTD) performance is -75.50%.
Shares of Merrimack Pharmaceuticals (NASDAQ:MACK) were up 4.7% during mid-day trading on Thursday following insider buying activity, AnalystRatingsNetwork.com reports. The stock traded as high as $7.30 and last traded at $7.18, with a volume of 1,969,486 shares changing hands. The stock had previously closed at $6.86.Merrimack Pharmaceuticals Inc (NASDAQ:MACK) ended the last trading day at $7.52. Company weekly volatility is calculated as 5.53% and price to cash ratio as 5.01. Merrimack Pharmaceuticals Inc (NASDAQ:MACK) showed a positive weekly performance of 10.59%.
Blackrock Kelso Capital Corp. (NASDAQ:BKCC) Director John R. Baron bought 10,000 shares of the stock in a transaction dated Wednesday, May 14th. The stock was purchased at an average cost of $8.53 per share, with a total value of $85,300.00. Following the completion of the acquisition, the director now directly owns 10,000 shares in the company, valued at approximately $85,300. Blackrock Kelso Capital Corp. (NASDAQ:BKCC) shares advanced 1.72% in last trading session and ended the day on $8.72.BKCC Gross Margin is 41.50% and its return on assets is 7.20%. Blackrock Kelso Capital Corp. (NASDAQ:BKCC) quarterly performance is -7.04%.
Leave a Reply